English | Español
Patient Daily | May 7, 2023

Penumbra, Inc. to Present at Upcoming Investor Conferences
Patient Daily | May 7, 2023

Ten Centura Hospitals Awarded Spring 2023 ‘A’ Hospital Safety Grade from Leapfrog Group
Patient Daily | May 7, 2023

Centura Health to Distribute $5 Million in Grants through the Equity & Advancement Fund
Patient Daily | May 7, 2023

CommonSpirit Health Welcomes Utah to Its Connected Ecosystem of Hospitals and Clinics
Patient Daily | May 7, 2023

EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS
Patient Daily | May 7, 2023

Stryker completes acquisition of Cerus Endovascular
Patient Daily | May 7, 2023

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily | May 7, 2023

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access